Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Annals of Internal Medicine
|
June 15, 1996
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators
R T D'Aquila, M D Hughes, V A Johnson, et al.
Annals of Internal Medicine
|
March 15, 1995
Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group
R T D'Aquila, V A Johnson, S L Welles, et al.
Nature Ecology & Evolution
|
June 24, 2020
Microbial transmission in animal social networks and the social microbiome
Amar Sarkar, Siobhán Harty, Katerina V-A Johnson, et al.
Annals of Internal Medicine
|
June 15, 1997
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team
M D Hughes, V A Johnson, M S Hirsch, et al.
AIDS (London, England)
|
July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Investigators
D R Kuritzkes, I Marschner, V A Johnson, et al.
AIDS (London, England)
|
September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370
D R Kuritzkes, R L Bassett, V A Johnson, et al.
JAMA
|
June 27, 1998
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel
M S Hirsch, B Conway, R T D'Aquila, et al.
JAMA
|
May 18, 2000
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel
M S Hirsch, F Brun-Vézinet, R T D'Aquila, et al.
The Journal of Infectious Diseases
|
January 7, 1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy
I C Marschner, A C Collier, R W Coombs, et al.
The Journal of Infectious Diseases
|
October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups
R W Coombs, S L Welles, C Hooper, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Annals of Internal Medicine
|
June 15, 1996
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators
R T D'Aquila, M D Hughes, V A Johnson, et al.
Annals of Internal Medicine
|
March 15, 1995
Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group
R T D'Aquila, V A Johnson, S L Welles, et al.
Nature Ecology & Evolution
|
June 24, 2020
Microbial transmission in animal social networks and the social microbiome
Amar Sarkar, Siobhán Harty, Katerina V-A Johnson, et al.
Annals of Internal Medicine
|
June 15, 1997
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team
M D Hughes, V A Johnson, M S Hirsch, et al.
AIDS (London, England)
|
July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Investigators
D R Kuritzkes, I Marschner, V A Johnson, et al.
AIDS (London, England)
|
September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370
D R Kuritzkes, R L Bassett, V A Johnson, et al.
JAMA
|
June 27, 1998
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel
M S Hirsch, B Conway, R T D'Aquila, et al.
JAMA
|
May 18, 2000
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel
M S Hirsch, F Brun-Vézinet, R T D'Aquila, et al.
The Journal of Infectious Diseases
|
January 7, 1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy
I C Marschner, A C Collier, R W Coombs, et al.
The Journal of Infectious Diseases
|
October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups
R W Coombs, S L Welles, C Hooper, et al.
Page
of 10